214 related articles for article (PubMed ID: 22461897)
1. Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.
Conti F; Alessandri C; Perricone C; Scrivo R; Rezai S; Ceccarelli F; Spinelli FR; Ortona E; Marianetti M; Mina C; Valesini G
PLoS One; 2012; 7(3):e33824. PubMed ID: 22461897
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus.
Szmyrka M; Pokryszko-Dragan A; Słotwiński K; Gruszka E; Korman L; Podemski R; Wiland P
Adv Clin Exp Med; 2019 Feb; 28(2):185-192. PubMed ID: 29963787
[TBL] [Abstract][Full Text] [Related]
3. Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
Ceccarelli F; Pirone C; Mina C; Mascolo A; Perricone C; Massaro L; Spinelli FR; Alessandri C; Valesini G; Conti F
PLoS One; 2019; 14(11):e0224437. PubMed ID: 31682630
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antiphospholipid antibodies in patients with overt myocardial dysfunction in systemic lupus erythematosus. A case-control study.
Gawalkar AA; Bahl A; Ahluwalia J; Sood A; Sharma A; Sharma S; Dhir V
Lupus; 2020 Oct; 29(12):1503-1508. PubMed ID: 32752919
[TBL] [Abstract][Full Text] [Related]
6. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
[TBL] [Abstract][Full Text] [Related]
7. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
8. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
Lapteva L; Nowak M; Yarboro CH; Takada K; Roebuck-Spencer T; Weickert T; Bleiberg J; Rosenstein D; Pao M; Patronas N; Steele S; Manzano M; van der Veen JW; Lipsky PE; Marenco S; Wesley R; Volpe B; Diamond B; Illei GG
Arthritis Rheum; 2006 Aug; 54(8):2505-14. PubMed ID: 16868971
[TBL] [Abstract][Full Text] [Related]
9. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
Pradhan V; Pandit P; Rajadhyaksha A; Patwardhan M; Surve P; Kamble P; Lecerf M; Bayry J; Kaveri S; Ghosh K; Nadkar MY
J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
[TBL] [Abstract][Full Text] [Related]
10. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
[TBL] [Abstract][Full Text] [Related]
11. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
Front Immunol; 2019; 10():1026. PubMed ID: 31134086
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.
Cavazzana I; Kumar R; Pozzari C; Ottaviani R; Fredi M; Piantoni S; Andreoli L; Tincani A; Franceschini F
Lupus; 2019 Aug; 28(9):1074-1081. PubMed ID: 31296140
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
[TBL] [Abstract][Full Text] [Related]
16. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus.
Hanly JG; Hong C; Smith S; Fisk JD
Arthritis Rheum; 1999 Apr; 42(4):728-34. PubMed ID: 10211887
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
[TBL] [Abstract][Full Text] [Related]
19. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
[TBL] [Abstract][Full Text] [Related]
20. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]